The place of doxepin among the anxiolytic-sedative drugs.
D000328:Adult; D000704:Analysis of Variance; D000928:Antidepressive Agents / Q000627:therapeutic use; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003710:Demography; D003990:Dibenzoxepins / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008297:Male; D008620:Meprobamate / Q000627:therapeutic use; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy; D010634:Phenobarbital / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales
D000928:Antidepressive Agents; D003990:Dibenzoxepins; D006993:Hypnotics and Sedatives; D006919:Hydroxyzine; D002707:Chlordiazepoxide; D008620:Meprobamate; D010634:Phenobarbital